These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 21406999

  • 1. Single photon emission computed tomography striatal asymmetry index may predict dopaminergic responsiveness in Parkinson disease.
    Contrafatto D, Mostile G, Nicoletti A, Raciti L, Luca A, Dibilio V, Lanzafame S, Distefano A, Drago F, Zappia M.
    Clin Neuropharmacol; 2011; 34(2):71-3. PubMed ID: 21406999
    [Abstract] [Full Text] [Related]

  • 2. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M, Djaldetti R, Melamed E, Sadeh M, Lampl Y.
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [Abstract] [Full Text] [Related]

  • 3. Baseline [(123) I]FP-CIT SPECT (DaTSCAN) severity correlates with medication use at 3 years in Parkinson's disease.
    Nissen T, Malek N, Grosset KA, Newman EJ, Patterson J, Hadley D, Grosset DG.
    Acta Neurol Scand; 2014 Mar; 129(3):204-8. PubMed ID: 23962145
    [Abstract] [Full Text] [Related]

  • 4. Are Dopa-responsive dystonia and Parkinson's disease related disorders? A case report.
    Eggers C, Volk AE, Kahraman D, Fink GR, Leube B, Schmidt M, Timmermann L.
    Parkinsonism Relat Disord; 2012 Jun; 18(5):666-8. PubMed ID: 22030322
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.
    Innis RB, Marek KL, Sheff K, Zoghbi S, Castronuovo J, Feigin A, Seibyl JP.
    Mov Disord; 1999 May; 14(3):436-42. PubMed ID: 10348466
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease Patients.
    Rossi C, Genovesi D, Marzullo P, Giorgetti A, Filidei E, Corsini GU, Bonuccelli U, Ceravolo R.
    Clin Neuropharmacol; 2017 May; 40(1):34-36. PubMed ID: 27941527
    [Abstract] [Full Text] [Related]

  • 10. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C, Frosini D, Volterrani D, De Feo P, Unti E, Nicoletti V, Kiferle L, Bonuccelli U, Ceravolo R.
    Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
    [Abstract] [Full Text] [Related]

  • 11. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
    Brücke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, Wöber C, Müller C, Podreka I.
    J Neural Transm Suppl; 1997 Apr; 50():9-24. PubMed ID: 9120429
    [Abstract] [Full Text] [Related]

  • 12. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease.
    Eshuis SA, Maguire RP, Leenders KL, Jonkman S, Jager PL.
    Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):200-9. PubMed ID: 16228235
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC.
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [Abstract] [Full Text] [Related]

  • 16. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls.
    Eshuis SA, Jager PL, Maguire RP, Jonkman S, Dierckx RA, Leenders KL.
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):454-62. PubMed ID: 19037637
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease.
    Happe S, Baier PC, Helmschmied K, Meller J, Tatsch K, Paulus W.
    J Neurol; 2007 Aug; 254(8):1037-43. PubMed ID: 17351722
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.